scPharmaceuticals Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
scPharmaceuticals Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to 2023.
  • scPharmaceuticals Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $15K.
  • scPharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $14.9M, a 80.8% decline from 2022.
  • scPharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $77.2M.
  • scPharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$2.53M, a 104% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $14.9M -$62.4M -80.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 $77.2M +$79.8M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 -$2.53M -$62.9M -104% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $60.3M +$46.8M +344% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
2019 $13.6M +$13.6M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-23
2018 -$8K* -$102M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-24
2017 $102M +$48.9M +92% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-21
2016 $53.2M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.